Global and United States Genetic Modification Therapies Market Report & Forecast 2023-2028

Report ID: 1830705 | Published Date: Jan 2025 | No. of Page: 85 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Genetic Modification Therapies Revenue in Genetic Modification Therapies Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Genetic Modification Therapies Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Genetic Modification Therapies Market Size for the Year 2017-2028
        1.2.2 Global Genetic Modification Therapies Market Size for the Year 2017-2028
    1.3 Genetic Modification Therapies Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Genetic Modification Therapies in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Genetic Modification Therapies Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Genetic Modification Therapies Market Dynamics
        1.4.1 Genetic Modification Therapies Industry Trends
        1.4.2 Genetic Modification Therapies Market Drivers
        1.4.3 Genetic Modification Therapies Market Challenges
        1.4.4 Genetic Modification Therapies Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Genetic Modification Therapies by Type
    2.1 Genetic Modification Therapies Market Segment by Type
        2.1.1 Gene Therapies
        2.1.2 Genetically Modified Cell Therapies
        2.1.3 RNA Therapies
        2.1.4 Gene Editing
    2.2 Global Genetic Modification Therapies Market Size by Type (2017, 2022 & 2028)
    2.3 Global Genetic Modification Therapies Market Size by Type (2017-2028)
    2.4 United States Genetic Modification Therapies Market Size by Type (2017, 2022 & 2028)
    2.5 United States Genetic Modification Therapies Market Size by Type (2017-2028)
3 Genetic Modification Therapies by Application
    3.1 Genetic Modification Therapies Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Diagnostics and Testing Laboratories
        3.1.3 Academic and Research Organizations
        3.1.4 Others
    3.2 Global Genetic Modification Therapies Market Size by Application (2017, 2022 & 2028)
    3.3 Global Genetic Modification Therapies Market Size by Application (2017-2028)
    3.4 United States Genetic Modification Therapies Market Size by Application (2017, 2022 & 2028)
    3.5 United States Genetic Modification Therapies Market Size by Application (2017-2028)
4 Global Genetic Modification Therapies Competitor Landscape by Company
    4.1 Global Genetic Modification Therapies Market Size by Company
        4.1.1 Top Global Genetic Modification Therapies Companies Ranked by Revenue (2021)
        4.1.2 Global Genetic Modification Therapies Revenue by Player (2017-2022)
    4.2 Global Genetic Modification Therapies Concentration Ratio (CR)
        4.2.1 Genetic Modification Therapies Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Genetic Modification Therapies in 2021
        4.2.3 Global Genetic Modification Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Genetic Modification Therapies Headquarters, Revenue in Genetic Modification Therapies Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Genetic Modification Therapies Headquarters and Area Served
        4.3.2 Global Genetic Modification Therapies Companies Revenue in Genetic Modification Therapies Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Genetic Modification Therapies Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Genetic Modification Therapies Market Size by Company
        4.5.1 Top Genetic Modification Therapies Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Genetic Modification Therapies Revenue by Players (2020, 2021 & 2022)
5 Global Genetic Modification Therapies Market Size by Region
    5.1 Global Genetic Modification Therapies Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Genetic Modification Therapies Market Size by Region (2017-2028)
        5.2.1 Global Genetic Modification Therapies Market Size by Region: 2017-2022
        5.2.2 Global Genetic Modification Therapies Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Genetic Modification Therapies Market Size YoY Growth 2017-2028
        6.1.2 North America Genetic Modification Therapies Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Genetic Modification Therapies Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Genetic Modification Therapies Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Genetic Modification Therapies Market Size YoY Growth 2017-2028
        6.3.2 Europe Genetic Modification Therapies Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Genetic Modification Therapies Market Size YoY Growth 2017-2028
        6.4.2 Latin America Genetic Modification Therapies Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Genetic Modification Therapies Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Genetic Modification Therapies Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 4D Molecular Therapeutics
        7.1.1 4D Molecular Therapeutics Company Details
        7.1.2 4D Molecular Therapeutics Business Overview
        7.1.3 4D Molecular Therapeutics Genetic Modification Therapies Introduction
        7.1.4 4D Molecular Therapeutics Revenue in Genetic Modification Therapies Business (2017-2022)
        7.1.5 4D Molecular Therapeutics Recent Development
    7.2 Abeona Therapeutics
        7.2.1 Abeona Therapeutics Company Details
        7.2.2 Abeona Therapeutics Business Overview
        7.2.3 Abeona Therapeutics Genetic Modification Therapies Introduction
        7.2.4 Abeona Therapeutics Revenue in Genetic Modification Therapies Business (2017-2022)
        7.2.5 Abeona Therapeutics Recent Development
    7.3 Allergan
        7.3.1 Allergan Company Details
        7.3.2 Allergan Business Overview
        7.3.3 Allergan Genetic Modification Therapies Introduction
        7.3.4 Allergan Revenue in Genetic Modification Therapies Business (2017-2022)
        7.3.5 Allergan Recent Development
    7.4 American Gene Technologies
        7.4.1 American Gene Technologies Company Details
        7.4.2 American Gene Technologies Business Overview
        7.4.3 American Gene Technologies Genetic Modification Therapies Introduction
        7.4.4 American Gene Technologies Revenue in Genetic Modification Therapies Business (2017-2022)
        7.4.5 American Gene Technologies Recent Development
    7.5 Merck Millipore
        7.5.1 Merck Millipore Company Details
        7.5.2 Merck Millipore Business Overview
        7.5.3 Merck Millipore Genetic Modification Therapies Introduction
        7.5.4 Merck Millipore Revenue in Genetic Modification Therapies Business (2017-2022)
        7.5.5 Merck Millipore Recent Development
    7.6 AbbVie
        7.6.1 AbbVie Company Details
        7.6.2 AbbVie Business Overview
        7.6.3 AbbVie Genetic Modification Therapies Introduction
        7.6.4 AbbVie Revenue in Genetic Modification Therapies Business (2017-2022)
        7.6.5 AbbVie Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Genetic Modification Therapies Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Genetic Modification Therapies Market Trends
    Table 3. Genetic Modification Therapies Market Drivers
    Table 4. Genetic Modification Therapies Market Challenges
    Table 5. Genetic Modification Therapies Market Restraints
    Table 6. Global Genetic Modification Therapies Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Genetic Modification Therapies Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Genetic Modification Therapies Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Genetic Modification Therapies Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Genetic Modification Therapies Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Genetic Modification Therapies Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Genetic Modification Therapies Revenue Share by Player, 2017-2022
    Table 13. Global Genetic Modification Therapies Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Genetic Modification Therapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Modification Therapies as of 2021)
    Table 15. Top Players of Genetic Modification Therapies in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Genetic Modification Therapies Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Genetic Modification Therapies Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Genetic Modification Therapies Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Genetic Modification Therapies Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Genetic Modification Therapies Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Genetic Modification Therapies Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Genetic Modification Therapies Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Genetic Modification Therapies Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Genetic Modification Therapies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Genetic Modification Therapies Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Genetic Modification Therapies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Genetic Modification Therapies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Genetic Modification Therapies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. 4D Molecular Therapeutics Company Details
    Table 31. 4D Molecular Therapeutics Business Overview
    Table 32. 4D Molecular Therapeutics Genetic Modification Therapies Product
    Table 33. 4D Molecular Therapeutics Revenue in Genetic Modification Therapies Business (2017-2022) & (US$ Million)
    Table 34. 4D Molecular Therapeutics Recent Development
    Table 35. Abeona Therapeutics Company Details
    Table 36. Abeona Therapeutics Business Overview
    Table 37. Abeona Therapeutics Genetic Modification Therapies Product
    Table 38. Abeona Therapeutics Revenue in Genetic Modification Therapies Business (2017-2022) & (US$ Million)
    Table 39. Abeona Therapeutics Recent Development
    Table 40. Allergan Company Details
    Table 41. Allergan Business Overview
    Table 42. Allergan Genetic Modification Therapies Product
    Table 43. Allergan Revenue in Genetic Modification Therapies Business (2017-2022) & (US$ Million)
    Table 44. Allergan Recent Development
    Table 45. American Gene Technologies Company Details
    Table 46. American Gene Technologies Business Overview
    Table 47. American Gene Technologies Genetic Modification Therapies Product
    Table 48. American Gene Technologies Revenue in Genetic Modification Therapies Business (2017-2022) & (US$ Million)
    Table 49. American Gene Technologies Recent Development
    Table 50. Merck Millipore Company Details
    Table 51. Merck Millipore Business Overview
    Table 52. Merck Millipore Genetic Modification Therapies Product
    Table 53. Merck Millipore Revenue in Genetic Modification Therapies Business (2017-2022) & (US$ Million)
    Table 54. Merck Millipore Recent Development
    Table 55. AbbVie Company Details
    Table 56. AbbVie Business Overview
    Table 57. AbbVie Genetic Modification Therapies Product
    Table 58. AbbVie Revenue in Genetic Modification Therapies Business (2017-2022) & (US$ Million)
    Table 59. AbbVie Recent Development
    Table 60. Research Programs/Design for This Report
    Table 61. Key Data Information from Secondary Sources
    Table 62. Key Data Information from Primary Sources
List of Figures
    Figure 1. Genetic Modification Therapies Product Picture
    Figure 2. Global Genetic Modification Therapies Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Genetic Modification Therapies Market Size 2017-2028 (US$ Million)
    Figure 4. United States Genetic Modification Therapies Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Genetic Modification Therapies Market Size 2017-2028 (US$ Million)
    Figure 6. United States Genetic Modification Therapies Market Share in Global 2017-2028
    Figure 7. Genetic Modification Therapies Report Years Considered
    Figure 8. Product Picture of Gene Therapies
    Figure 9. Product Picture of Genetically Modified Cell Therapies
    Figure 10. Product Picture of RNA Therapies
    Figure 11. Product Picture of Gene Editing
    Figure 12. Global Genetic Modification Therapies Market Share by Type in 2022 & 2028
    Figure 13. Global Genetic Modification Therapies Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Genetic Modification Therapies Market Share by Type (2017-2028)
    Figure 15. United States Genetic Modification Therapies Market Share by Type in 2022 & 2028
    Figure 16. United States Genetic Modification Therapies Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Genetic Modification Therapies Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Diagnostics and Testing Laboratories
    Figure 20. Product Picture of Academic and Research Organizations
    Figure 21. Product Picture of Others
    Figure 22. Global Genetic Modification Therapies Market Share by Application in 2022 & 2028
    Figure 23. Global Genetic Modification Therapies Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. Global Genetic Modification Therapies Market Share by Application (2017-2028)
    Figure 25. United States Genetic Modification Therapies Market Share by Application in 2022 & 2028
    Figure 26. United States Genetic Modification Therapies Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. United States Genetic Modification Therapies Market Share by Application (2017-2028)
    Figure 28. North America Genetic Modification Therapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. U.S. Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Canada Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Europe Genetic Modification Therapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. Germany Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. France Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. U.K. Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Italy Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Russia Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Genetic Modification Therapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. China Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Japan Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. South Korea Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. India Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Australia Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Taiwan Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Indonesia Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Thailand Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Malaysia Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Philippines Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Latin America Genetic Modification Therapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Mexico Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Brazil Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Argentina Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Genetic Modification Therapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Turkey Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. U.A.E Genetic Modification Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. 4D Molecular Therapeutics Revenue Growth Rate in Genetic Modification Therapies Business (2017-2022)
    Figure 57. Abeona Therapeutics Revenue Growth Rate in Genetic Modification Therapies Business (2017-2022)
    Figure 58. Allergan Revenue Growth Rate in Genetic Modification Therapies Business (2017-2022)
    Figure 59. American Gene Technologies Revenue Growth Rate in Genetic Modification Therapies Business (2017-2022)
    Figure 60. Merck Millipore Revenue Growth Rate in Genetic Modification Therapies Business (2017-2022)
    Figure 61. AbbVie Revenue Growth Rate in Genetic Modification Therapies Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
4D Molecular Therapeutics
Abeona Therapeutics
Allergan
American Gene Technologies
Merck Millipore
AbbVie
Frequently Asked Questions
Genetic Modification Therapies report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Genetic Modification Therapies report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Genetic Modification Therapies report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports